Globus Medical (GMED) Total Non-Current Liabilities (2011 - 2026)
Globus Medical (GMED) posted Total Non-Current Liabilities of $686.7 million for Q1 2026, down 3.04% on a QoQ basis from $708.2 million in Q4 2025, and up 35.97% year-over-year from $505.0 million in Q1 2025.
Globus Medical (GMED) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Globus Medical's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $686.7 million for Q1 2026.
- Quarterly Total Non-Current Liabilities rose 35.97% year-over-year to $686.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $686.7 million (up 35.97% YoY) and the FY2025 annual result came in at $708.2 million, down 32.74% from the prior year.
- Total Non-Current Liabilities was $686.7 million for Q1 2026 at Globus Medical, down from $708.2 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $1.1 billion in Q3 2023 and bottomed at $145.3 million in Q1 2022.
- A 5-year average of $607.9 million and a median of $671.7 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 512.3% — and 2025, when it sank 44.5%.
- Globus Medical's Total Non-Current Liabilities stood at $219.4 million in 2022, then jumped by 384.73% to $1.1 billion in 2023, then fell by 1.0% to $1.1 billion in 2024, then sank by 32.74% to $708.2 million in 2025, then fell by 3.04% to $686.7 million in 2026.
- Business Quant data shows GMED's Total Non-Current Liabilities at $686.7 million in Q1 2026, $708.2 million in Q4 2025, and $671.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Globus Medical | 10.21 Bn | 9.58 Bn | 525.79 Mn | 686.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 686.67 Mn |
| Dec 31, 2025 | 708.17 Mn |
| Sep 30, 2025 | 671.73 Mn |
| Jun 30, 2025 | 560.43 Mn |
| Mar 31, 2025 | 505.03 Mn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 993.66 Mn |
| Jun 30, 2024 | 992.22 Mn |
| Mar 31, 2024 | 909.94 Mn |
| Dec 31, 2023 | 1.06 Bn |
| Sep 30, 2023 | 1.15 Bn |
| Jun 30, 2023 | 162.05 Mn |
| Mar 31, 2023 | 169.92 Mn |
| Dec 31, 2022 | 219.41 Mn |
| Sep 30, 2022 | 199.80 Mn |
| Jun 30, 2022 | 147.31 Mn |
| Mar 31, 2022 | 145.29 Mn |
| Dec 31, 2021 | 203.23 Mn |
| Sep 30, 2021 | 176.43 Mn |
| Jun 30, 2021 | 142.95 Mn |